Molecular Templates to Present at the 2017 BIO Investor Forum

AUSTIN, Texas, Oct. 06, 2017 -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer, will provide a corporate overview at the 2017 BIO Investor Forum, being held October 17-18 in San Francisco, California.

BIO Investor Forum
Date:               Tuesday, October 17
Time:               10:30am Pacific Time
Location:          Westin St. Francis, San Francisco, Elizabethan C Ballroom
Webcast:          http://www.veracast.com/webcasts/bio/investorforum2017/25111335172.cfm

About Molecular Templates 
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases.  For additional information, please visit Molecular Templates’ website at ​www.mtem.com​.

Investor Contact:
Andrew McDonald, Ph.D.
[email protected]
646-597-6987